Gastrointestinal Drugs Market Global Briefing 2022: Ukraine-Russia War Impact
Report Highlights
Including: Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals
Global gastrointestinal drugs market was worth $71.7 billion in 2021, it was the eighth largest segment within the market accounting for 4.9%. In terms of per capita consumption, the market was $9.3 and in terms of global GDP, the market was 0.08%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.9% preceded and followed by metabolic disorders drugs at 5.6% and ophthalmology drugs at 3.4% respectively.
Gastrointestinal Drugs Market Global Briefing 2022: Ukraine-Russia War Impact provides strategists, marketers and senior management with the critical information they need to assess the global gastrointestinal drugs sector.
Reasons to Purchase
- Fully updated for 2022 with Ukraine-Russia War Impact.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
Gastrointestinal Drugs Market Global Briefing 2022: Ukraine-Russia War Impact from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the gastrointestinal drugs market revenues, covering both the historic growth of the market and forecasting the future.
- Market segmentations break down the key sub sectors which make up the market.
- The regional breakdowns section gives the size of the market geographically.
- The trends and strategies section highlights the likely future developments in the gastrointestinal drugs market and suggests approaches.
Scope
Markets Covered: Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals
Geographic scope: Asia Pacific, North America, Western Europe, Eastern Europe, South America, Middle East, Africa
Time series: Five years historic and forecast
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Global Gastrointestinal Drugs Market, Historic Market Size, 2016-2021, $
- Table 2 : Global Gastrointestinal Drugs Market, Forecast Market Size, 2021-2026, $
- Table 3 : Global Gastrointestinal Drugs Market, Split By Segment, 2021, $
- Table 4 : Global Gastrointestinal Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Table 5 : Global Gastrointestinal Drugs Market, Split By Region, 2021, $
- Table 6 : Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
- Table 7 : Gastrointestinal Drugs Market Data Sources
- Figure 1 : Global Gastrointestinal Drugs Market, Historic Market Size, 2016-2021, $
- Figure 2 : Global Gastrointestinal Drugs Market, Forecast Market Size, 2021-2026, $
- Figure 3 : Global Gastrointestinal Drugs Market, Split By Segment, 2021, $
- Figure 4 : Global Gastrointestinal Drugs Market, Historic And Forecast, Split By Segment, 2016-2026
- Figure 5 : Global Gastrointestinal Drugs Market, Split By Region, 2021, $
- Figure 6 : Global Gastrointestinal Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2016-2026
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Similar Reports from TBRC (Publisher)
Gastrointestinal Drugs Global Market Competitor Briefing 2021
Including: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals
Covering: Takeda Pharmaceuticals; Bayer AG; Abbott Laboratories; Otsuka Holdings Co ltd; Johnson & Johnson
Takeda Pharmaceuticals was the largest competitor with 13.54% of the market followed by Bayer AG and Abbott Laboratories
Gastrointestinal Drugs Global Market Competitor Briefing 2021 provides strategists, marketers and senior management with the critical information ...
Gastrointestinal Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery
Including: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals
Covering: Bayer AG; Takeda Pharmaceuticals; Otsuka Pharmaceutical Co., Ltd; Johnson & Johnson; Reckitt Benckiser Group plc
Bayer AG was the largest competitor with 11.52% of the market followed by Takeda Pharmaceuticals and Otsuka Pharmaceutical Co., Ltd.
Gastrointestinal Drugs Investment Competitor Outlook 2020: Covid 19 Impact and Recovery ...
Gastrointestinal Drugs Market Global Briefing 2020: Covid 19 Impact and Recovery
Including: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals
Gastrointestinal Drugs Market Competitor Briefing 2019
Including: Antiulcerants; Vitamin And Minerals; Antacids; Antiemetics And Antinauseants; Antiobesity; Antidiarrhoeals
Covering: Takeda Pharmaceuticals; Astrazeneca; Sanofi S.A.; Otsuka Pharmaceutical Co.; Valeant Pharmaceuticals Intl Inc.
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research
Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market
Gastrointestinal Drugs Market Global Briefing 2019
Research Methodology
The report is built on information collected through secondary sources and analysis done by The Business Research Company (TBRC). The secondary sources include the data published by statistical bodies, government agencies, market intelligence databases and annual reports. Insights on the current market scenario, historic and forecast market drivers were gathered from industry reports and news articles.
Note on ...
Gastrointestinal Drugs Market Global Briefing 2018
Including: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
Covering: Takeda Pharmaceuticals, Allergan Plc. And Novo Nordisk A/S
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data –
Our datasets are created using a wide range of proprietary and public sources including leading government bodies, associations, regulatory agencies, scientific journals and market intelligence ...
Gastrointestinal Drugs Market Global Briefing 2017
Including: Antiulcerants, Vitamin And Minerals, Antacids, Antiemetics And Antinauseants, Antiobesity, Antidiarrhoeals
Covering: Takeda Pharmaceuticals, Allergan Plc., Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson, Bayer AG, Otsuka Pharmaceutical Co., Ltd.
Research Methodology
The Business Research Company’s reports are based on the methodology below.
Data
Our datasets are created using a wide range of proprietary and public sources including leading government ...